Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
about
Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic ModelingMulti-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B.Optimizing Polymyxin Combinations Against Resistant Gram-Negative BacteriaParadoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumanniiOptimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.Synergistic combinations of polymyxins.Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii.Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro InformationIn Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae.Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategiesDynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa.Reply to Dr Hatipoglu et al and to Dr Mancini et al.Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens.Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.
P2860
Q28550711-C77FEDB3-DAAD-443E-9DF2-C285ED5CE7D2Q36319990-194BA6C6-F846-483D-8B01-973DEE066577Q36363261-17B5D081-BFA3-4211-8EF6-3D9455BE5135Q37023206-FCEA97E3-0670-4299-8393-F0E1471145A8Q37538623-358F13E0-7D3E-4867-BC97-9B947EB72B94Q37586960-5618C6C8-982C-4007-BC22-36026146F480Q37728145-2B5F2F0D-6CC8-43B7-BE10-D20F7C707106Q38853629-A3AFD368-8D46-4F1B-9EFC-C5794AA8B194Q38964046-9AB4CCBF-8D57-47BD-95E2-5B1F7A2670E3Q39170967-523FE8BB-0B20-40A8-82FB-C2E02A30E52FQ39333751-8D712A34-5F42-469D-A47F-9A8DDF13C3C8Q40237248-7FE9E771-5D1C-4F34-9364-7F7B09D23349Q40587067-D01B422A-0B87-4183-A3CD-2457F68E737AQ40802708-B1C4AD80-5036-4640-97A3-C7622CEED46EQ42717931-89F1F15A-1A68-4F91-A0CE-6BA0BCEDBB8EQ47600163-94D86CD6-F4AB-4AE6-BAA3-C5F71BFD97B8Q52715802-7C30744A-1E78-4695-A8C6-8C03378CFE7AQ53707227-2AF5C633-4538-4853-BCBB-3D2E79AD9D44
P2860
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Colistin and doripenem combina ...... and prevention of resistance.
@ast
Colistin and doripenem combina ...... and prevention of resistance.
@en
type
label
Colistin and doripenem combina ...... and prevention of resistance.
@ast
Colistin and doripenem combina ...... and prevention of resistance.
@en
prefLabel
Colistin and doripenem combina ...... and prevention of resistance.
@ast
Colistin and doripenem combina ...... and prevention of resistance.
@en
P2093
P2860
P50
P356
P1476
Colistin and doripenem combina ...... and prevention of resistance.
@en
P2093
Alan Forrest
Brian T Tsuji
Gauri G Rao
Neang S Ly
Patricia N Holden
Phillip J Bergen
P2860
P304
P356
10.1093/JAC/DKU567
P407
P577
2015-02-23T00:00:00Z